{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:43:59Z","timestamp":1758969839110,"version":"3.41.2"},"reference-count":17,"publisher":"Cardiofront, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.4022\/jafib.1456","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T18:29:39Z","timestamp":1513016979000},"source":"Crossref","is-referenced-by-count":11,"title":["Safety of The Direct Oral Anticoagulant Edoxaban for Atrial Fibrillation After Cardiac Surgery: Pilot Study"],"prefix":"10.4022","volume":"9","author":[{"given":"Akira","family":"Sezai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Osaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Yaoita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munehito","family":"Arimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Hata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motomi","family":"Shiono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2440","published-online":{"date-parts":[[2016,10,31]]},"reference":[{"key":"key_R01","first-page":"7","article-title":"Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review.","volume-title":"Thromb. Res.","year":"2015"},{"key":"key_R02","first-page":"1095","article-title":"Novel oral anticoagulants vs warfarin for the management of postoperative atrial fibrillation: clinical outcomes and cost analysis.","volume-title":"Am. J. Surg.","year":"2015"},{"key":"key_R03","first-page":"2719","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.","volume":"33 (21)","year":"2012","journal-title":"Eur. Heart J."},{"key":"key_R04","first-page":"1139","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation.","volume":"361 (12)","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"key_R05","first-page":"e101","article-title":"2011 ACCF\/AHA\/HRS focused updates incorporated into the ACC\/AHA\/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.","volume":"57 (11)","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"key_R06","first-page":"2093","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation.","volume":"369 (22)","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"key_R07","first-page":"981","article-title":"Apixaban versus warfarin in patients with atrial fibrillation.","volume":"365 (11)","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"key_R08","first-page":"1997","article-title":"Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013).","volume":"78 (8)","year":"2014","journal-title":"Circ. J."},{"key":"key_R09","first-page":"e1","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.","volume":"64 (21)","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"key_R10","first-page":"883","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.","volume":"365 (10)","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"key_R11","first-page":"895","article-title":"Study of the factors related to atrial fibrillation after coronary artery bypass grafting: a search for a marker to predict the occurrence of atrial fibrillation before surgical intervention.","volume":"137 (4)","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"key_R12","first-page":"1241","article-title":"Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study.","volume":"144 (5)","year":"2012","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"key_R13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5761\/atcs.oa.15-00089","article-title":"A study on the occurrence and prevention of perioperative stroke after coronary artery bypass grafting.","volume":"21","year":"2015","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"key_R14","first-page":"957","article-title":"Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: Prevention of Atrial Fibrillation After Cardiac Surgery With Landiolol Hydrochloride for Left Ventricular Dysfunction (PLATON) trial.","volume":"150 (4)","year":"2015","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"key_R15","first-page":"261","article-title":"The role of \u03b2-blockers in cardiac perioperative management.","volume":"20 (4)","year":"2014","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"key_R16","first-page":"1630","article-title":"Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.","volume":"126 (13)","year":"2012","journal-title":"Circulation"},{"key":"key_R17","first-page":"488","article-title":"Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).","volume":"131 (5)","year":"2015","journal-title":"Circulation"}],"container-title":["Journal of Atrial Fibrillation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T18:29:41Z","timestamp":1513016981000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jafib.com\/published.php?type=full&id=1456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,10,31]]},"published-print":{"date-parts":[[2016]]}},"alternative-id":["10.4022\/jafib.1456"],"URL":"https:\/\/doi.org\/10.4022\/jafib.1456","relation":{},"ISSN":["1941-6911"],"issn-type":[{"type":"electronic","value":"1941-6911"}],"subject":[],"published":{"date-parts":[[2016]]},"article-number":"1456"}}